| |
| |
|
| Insider
Information: |
Paggiarino Dario A. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
67,080 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$29,683 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
67,080 |
|
|
| Total
Value |
$29,683 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
EyePoint Pharmaceuticals Inc |
EYPT |
|
2024-03-30 |
67,080 |
2018-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-03-30 |
4 |
D |
$20.67 |
$528,036 |
D/D |
(25,546) |
67,080 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,404 |
92,626 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-02-09 |
4 |
D |
$28.80 |
$146,390 |
D/D |
(5,083) |
42,222 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,800 |
47,305 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-26 |
4 |
OE |
$12.90 |
$644,047 |
D/D |
49,325 |
85,830 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-26 |
4 |
S |
$25.41 |
$1,265,539 |
D/D |
(49,325) |
36,505 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-25 |
4 |
S |
$25.00 |
$15,000 |
D/D |
(600) |
36,505 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-25 |
4 |
OE |
$12.90 |
$7,809 |
D/D |
600 |
37,105 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-24 |
4 |
S |
$25.01 |
$281,415 |
D/D |
(11,251) |
36,505 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-24 |
4 |
OE |
$12.90 |
$146,426 |
D/D |
11,251 |
47,756 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-23 |
4 |
S |
$25.00 |
$128,375 |
D/D |
(5,135) |
36,505 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-23 |
4 |
OE |
$12.90 |
$66,954 |
D/D |
5,135 |
41,640 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-08 |
4 |
S |
$21.13 |
$484,124 |
D/D |
(22,913) |
36,505 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-08 |
4 |
OE |
$3.26 |
$74,696 |
D/D |
22,913 |
59,418 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-06 |
4 |
D |
$20.40 |
$91,535 |
D/D |
(4,487) |
36,505 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,285 |
40,992 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-12-13 |
4 |
OE |
$10.13 |
$14,770 |
D/D |
1,458 |
27,165 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-12-13 |
4 |
S |
$20.00 |
$29,160 |
D/D |
(1,458) |
25,707 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-12-04 |
4 |
S |
$22.00 |
$673,750 |
D/D |
(30,625) |
25,707 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-12-04 |
4 |
OE |
$10.13 |
$310,231 |
D/D |
30,625 |
56,332 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-02-09 |
4 |
D |
$4.17 |
$15,612 |
D/D |
(3,744) |
25,707 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2023-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,800 |
29,451 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-02-28 |
4 |
D |
$9.95 |
$12,875 |
D/D |
(1,294) |
18,651 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,105 |
19,945 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Chief Medical Officer |
• – – |
2022-02-09 |
4 |
D |
$10.13 |
$17,434 |
D/D |
(1,721) |
15,840 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
